Finance

Beta
Lists
002772:SHE
Tianshui Zhongxing Bio-technology Co Ltd
CNÂ¥12.50
-0.87%
(-0.11) 1D
Jun 5, 2:26:57 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002772...
Open
CNÂ¥12.68
High
CNÂ¥12.86
Low
CNÂ¥12.47
Mkt. cap
4.83B
Avg. vol.
10.19M
Volume
6.42M
Dividend
3.60%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 19, 2026
P/E ratio
10.52
52-wk high
CNÂ¥19.73
52-wk low
CNÂ¥7.47
EPS
CNÂ¥1.19
Shares outstanding
374.74M
No. of employees
9K
Open
CNÂ¥12.68
High
CNÂ¥12.86
Low
CNÂ¥12.47
Mkt. cap
4.83B
Avg. vol.
10.19M
Volume
6.42M
Dividend
3.60%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 19, 2026
P/E ratio
10.52
52-wk high
CNÂ¥19.73
52-wk low
CNÂ¥7.47
EPS
CNÂ¥1.19
Shares outstanding
374.74M
No. of employees
9K
News stories
From sources across the web
About Tianshui Zhongxing Bio-technology Co Ltd
CEO-
Employees9.18K
FoundedNov 18, 2005
Headquarters-
SectorFood
Websitetszxjy.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
435.21M
567.54M
622.98M
601.97M
Cost of goods sold
368.26M
371.41M
395.22M
365.10M
Cost of revenue
368.26M
371.41M
395.22M
365.10M
Research and development expenses
3.10M
4.67M
6.52M
2.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.24M
52.90M
84.05M
60.15M
Operating expense
47.84M
52.91M
109.07M
63.46M
Total operating expenses
416.10M
424.32M
504.28M
428.56M
Operating income
19.10M
143.22M
118.69M
173.41M
Other non operating income
14.68M
-9.91M
-8.09M
-3.31M
EBT including unusual items
20.18M
135.71M
132.01M
163.34M
EBT excluding unusual items
23.73M
135.42M
108.65M
162.37M
Income tax expense
-
-
1.21M
-
Effective tax rate
-
-
0.91%
-
Other operating expenses
-9.33M
-4.70M
17.66M
643.34K
Net income
20.82M
135.33M
130.62M
162.70M
Net profit margin
4.78%
23.84%
20.97%
27.03%
Earnings per share
-
-
-
-
Interest and investment income
13.90M
7.38M
7.90M
6.88M
Interest expense
-15.15M
-14.07M
-15.75M
-14.61M
Net interest expenses
-1.25M
-6.69M
-7.85M
-7.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
71.53M
214.81M
196.62M
251.34M
Gain or loss from assets sale
4.38M
-4.38M
6.54M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more